UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 207

Sortiert nach

The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program

Antimicrobial agents and chemotherapy, 2019-07, Vol.63 (7)

2019

Link zum Volltext

Verfügbarkeit prüfen

Ceftolozane-Tazobactam Activity against Pseudomonas aeruginosa Clinical Isolates from U.S. Hospitals: Report from the PACTS Antimicrobial Surveillance Program, 2012 to 2015

Antimicrobial agents and chemotherapy, 2017-07, Vol.61 (7)

2017

Link zum Volltext

Verfügbarkeit prüfen

Echinocandin and Triazole Antifungal Susceptibility Profiles for Clinical Opportunistic Yeast and Mold Isolates Collected from 2010 to 2011: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values for Characterization of Geographic and Temporal Trends of Antifungal Resistance

Journal of Clinical Microbiology, 2013-08, Vol.51 (8), p.2571-2581

2013

Link zum Volltext

Verfügbarkeit prüfen

Differential Activity of the Oral Glucan Synthase Inhibitor SCY-078 against Wild-Type and Echinocandin-Resistant Strains of Candida Species

Antimicrobial agents and chemotherapy, 2017-08, Vol.61 (8)

2017

Link zum Volltext

Verfügbarkeit prüfen

Surveillance of Omadacycline Activity against Clinical Isolates from a Global Collection (North America, Europe, Latin America, Asia-Western Pacific), 2010-2011

Antimicrobial agents and chemotherapy, 2017-05, Vol.61 (5)

2017

Link zum Volltext

Verfügbarkeit prüfen

Candida Bloodstream Infections: Comparison of Species Distributions and Antifungal Resistance Patterns in Community-Onset and Nosocomial Isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009

Antimicrobial Agents and Chemotherapy, 2011-02, Vol.55 (2), p.561-566

2011

Link zum Volltext

Verfügbarkeit prüfen

Geographic Variations in Species Distribution and Echinocandin and Azole Antifungal Resistance Rates among Candida Bloodstream Infection Isolates: Report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009)

Journal of Clinical Microbiology, 2011-01, Vol.49 (1), p.396-399

2011

Link zum Volltext

Verfügbarkeit prüfen

Azole Resistance in Aspergillus fumigatus Isolates from the ARTEMIS Global Surveillance Study Is Primarily Due to the TR/L98H Mutation in the cyp51A Gene

Antimicrobial Agents and Chemotherapy, 2011-09, Vol.55 (9), p.4465-4468

2011

Link zum Volltext

Verfügbarkeit prüfen

Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program

Antimicrobial agents and chemotherapy, 2017-03, Vol.61 (3)

2017

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activities of Isavuconazole and Comparator Antifungal Agents Tested against a Global Collection of Opportunistic Yeasts and Molds

Journal of Clinical Microbiology, 2013-08, Vol.51 (8), p.2608-2616

2013

Link zum Volltext

Verfügbarkeit prüfen

Candida guilliermondii and Other Species of Candida Misidentified as Candida famata: Assessment by Vitek 2, DNA Sequencing Analysis, and Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry in Two Global Antifungal Surveillance Programs

Journal of Clinical Microbiology, 2013-01, Vol.51 (1), p.117-124

2013

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activity of a New Oral Glucan Synthase Inhibitor (MK-3118) Tested against Aspergillus spp. by CLSI and EUCAST Broth Microdilution Methods

Antimicrobial Agents and Chemotherapy, 2013-02, Vol.57 (2), p.1065-1068

2013

Link zum Volltext

Verfügbarkeit prüfen

Antifungal susceptibilities of opportunistic filamentous fungal pathogens from the Asia and Western Pacific Region: data from the SENTRY Antifungal Surveillance Program (2011-2019)

Journal of antibiotics, 2021-08, Vol.74 (8), p.519-527

2021

Link zum Volltext

Verfügbarkeit prüfen

Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010-2012)

Journal of antibiotics, 2015-09, Vol.68 (9), p.556-561

2015

Link zum Volltext

Verfügbarkeit prüfen

Geographic Distribution and Antifungal Susceptibility of the Newly Described Species Candida orthopsilosis and Candida metapsilosis in Comparison to the Closely Related Species Candida parapsilosis

Journal of Clinical Microbiology, 2008-08, Vol.46 (8), p.2659-2664

2008

Link zum Volltext

Verfügbarkeit prüfen

Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008–2009)

Diagnostic microbiology and infectious disease, 2010-11, Vol.68 (3), p.278-283

2010

Link zum Volltext

Verfügbarkeit prüfen

Trends in the susceptibility of U.S. Acinetobacter baumannii-calcoaceticus species complex and Stenotrophomonas maltophilia isolates to minocycline, 2014-2021

Microbiology spectrum, 2023-12, Vol.11 (6), p.e0198123-e0198123

2023

Link zum Volltext

Verfügbarkeit prüfen

Frequency of fks Mutations among Candida glabrata Isolates from a 10-Year Global Collection of Bloodstream Infection Isolates

Antimicrobial Agents and Chemotherapy, 2014-01, Vol.58 (1), p.577-580

2014

Link zum Volltext

Verfügbarkeit prüfen

Ceftolozane-tazobactam activity against clinical isolates of Pseudomonas aeruginosa from ICU patients with pneumonia: United States, 2015–2018

International journal of infectious diseases, 2021-11, Vol.112, p.321-326

2021

Link zum Volltext

Verfügbarkeit prüfen

Activities of E1210 and Comparator Agents Tested by CLSI and EUCAST Broth Microdilution Methods against Fusarium and Scedosporium Species Identified Using Molecular Methods

Antimicrobial Agents and Chemotherapy, 2012-01, Vol.56 (1), p.352-357

2012

Link zum Volltext

Verfügbarkeit prüfen

Triazole and Echinocandin MIC Distributions with Epidemiological Cutoff Values for Differentiation of Wild-Type Strains from Non-Wild-Type Strains of Six Uncommon Species of Candida

Journal of Clinical Microbiology, 2011-11, Vol.49 (11), p.3800-3804

2011

Link zum Volltext

Verfügbarkeit prüfen

Low Prevalence of fks1 Hot Spot 1 Mutations in a Worldwide Collection of Candida Strains

Antimicrobial Agents and Chemotherapy, 2010-06, Vol.54 (6), p.2655-2659

2010

Link zum Volltext

Verfügbarkeit prüfen

Surveillance of omadacycline activity tested against clinical isolates from the USA: report from the SENTRY Antimicrobial Surveillance Program, 2019

Journal of global antimicrobial resistance., 2021-12, Vol.27, p.337-351

2021

Link zum Volltext

Verfügbarkeit prüfen

Has Antifungal Susceptibility Testing Come of Age?

Clinical infectious diseases, 2002-10, Vol.35 (8), p.982-989

2002

Link zum Volltext

Verfügbarkeit prüfen

Caspofungin Etest Susceptibility Testing of Candida Species: Risk of Misclassification of Susceptible Isolates of C. glabrata and C. krusei when Adopting the Revised CLSI Caspofungin Breakpoints

Antimicrobial Agents and Chemotherapy, 2012-07, Vol.56 (7), p.3965-3968

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 207

Suche als RSS-Feed

Aktive Filter

KollektioneBooks on EBSCOhost

ThemaMicrobial Sensitivity Tests

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(207)
Mit Volltextzugriff
(198)

Publikationsform

Artikel
(207)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(194)
Science & Technology
(194)
Microbiology
(176)
Humans
(169)
Biological And Medical Sciences
(133)
Infectious Diseases
(125)
Medical Sciences
(114)
Antifungal Agents - Pharmacology
(86)
Pharmacology. Drug Treatments
(81)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(80)
Pharmacology & Pharmacy
(77)
Anti-Bacterial Agents - Pharmacology
(71)
Candida - Drug Effects
(54)
Antifungal Agents
(49)
Drug Resistance, Microbial
(39)
Fundamental And Applied Biological Sciences. Psychology
(39)
Antibacterial Agents
(35)
Candida
(31)
Mycology
(30)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program

Ceftolozane-Tazobactam Activity against Pseudomonas aeruginosa Clinical Isolates from U.S. Hospitals: Report from the PACTS Antimicrobial Surveillance Program, 2012 to 2015

Echinocandin and Triazole Antifungal Susceptibility Profiles for Clinical Opportunistic Yeast and Mold Isolates Collected from 2010 to 2011: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values for Characterization of Geographic and Temporal Trends of Antifungal Resistance

Differential Activity of the Oral Glucan Synthase Inhibitor SCY-078 against Wild-Type and Echinocandin-Resistant Strains of Candida Species

Surveillance of Omadacycline Activity against Clinical Isolates from a Global Collection (North America, Europe, Latin America, Asia-Western Pacific), 2010-2011

Candida Bloodstream Infections: Comparison of Species Distributions and Antifungal Resistance Patterns in Community-Onset and Nosocomial Isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009

Geographic Variations in Species Distribution and Echinocandin and Azole Antifungal Resistance Rates among Candida Bloodstream Infection Isolates: Report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009)

Azole Resistance in Aspergillus fumigatus Isolates from the ARTEMIS Global Surveillance Study Is Primarily Due to the TR/L98H Mutation in the cyp51A Gene

Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program

In Vitro Activities of Isavuconazole and Comparator Antifungal Agents Tested against a Global Collection of Opportunistic Yeasts and Molds

Candida guilliermondii and Other Species of Candida Misidentified as Candida famata: Assessment by Vitek 2, DNA Sequencing Analysis, and Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry in Two Global Antifungal Surveillance Programs

In Vitro Activity of a New Oral Glucan Synthase Inhibitor (MK-3118) Tested against Aspergillus spp. by CLSI and EUCAST Broth Microdilution Methods

Antifungal susceptibilities of opportunistic filamentous fungal pathogens from the Asia and Western Pacific Region: data from the SENTRY Antifungal Surveillance Program (2011-2019)

Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010-2012)

Geographic Distribution and Antifungal Susceptibility of the Newly Described Species Candida orthopsilosis and Candida metapsilosis in Comparison to the Closely Related Species Candida parapsilosis

Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008–2009)

Trends in the susceptibility of U.S. Acinetobacter baumannii-calcoaceticus species complex and Stenotrophomonas maltophilia isolates to minocycline, 2014-2021

Frequency of fks Mutations among Candida glabrata Isolates from a 10-Year Global Collection of Bloodstream Infection Isolates

Ceftolozane-tazobactam activity against clinical isolates of Pseudomonas aeruginosa from ICU patients with pneumonia: United States, 2015–2018

Activities of E1210 and Comparator Agents Tested by CLSI and EUCAST Broth Microdilution Methods against Fusarium and Scedosporium Species Identified Using Molecular Methods

Triazole and Echinocandin MIC Distributions with Epidemiological Cutoff Values for Differentiation of Wild-Type Strains from Non-Wild-Type Strains of Six Uncommon Species of Candida

Low Prevalence of fks1 Hot Spot 1 Mutations in a Worldwide Collection of Candida Strains

Surveillance of omadacycline activity tested against clinical isolates from the USA: report from the SENTRY Antimicrobial Surveillance Program, 2019

Has Antifungal Susceptibility Testing Come of Age?

Caspofungin Etest Susceptibility Testing of Candida Species: Risk of Misclassification of Susceptible Isolates of C. glabrata and C. krusei when Adopting the Revised CLSI Caspofungin Breakpoints

Aktive Filter

Suchergebnisse filtern